« Back to Record
Kerklaan, B. M., Mergui-Roelvink, M., Schellens, J. J., Diéras, V., Le Tourneau, C., Huitema, A. D., Rosing, H., Beijnen, J. H., Marreaud, S., Govaerts, A.-S., Awada, A., & Piccart-Gebhart, M. (2013). Erratum: Phase i study of lonafarnib (SCH66336) in combination with trastuzumab plus paclitaxel in Her2/neu overexpressing breast cancer: EORTC study 16023 (Cancer Chemother Pharmacol (2013) 71 (53-62)). Cancer chemotherapy and pharmacology, 71(2), 553. doi:10.1007/s00280-012-2064-y
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/203924



